Phase-Transformation Nanoparticle-Mediated Sonodynamic Therapy: An Effective Modality to Enhance Anti-Tumor Immune Response by Inducing Immunogenic Cell Death in Breast Cancer
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Purpose: Immunologically quiescent of breast cancer cells has been recognized as the key impediment for the breast cancer immunotherapy. In this study, we aimed to investigate the role of nanoparticle-mediated sonodynamic therapy (SDT) in promoting anti-tumor immune of breast cancer cells and its potential immune mechanisms. Materials and Methods: The phase-transformation nanoparticles (LIP-PFH nanoparticles) were in-house prepared and its physiochemical characters were detected. The CCK-8 assay, apoptosis analysis and Balb/c tumor model establishment were used to explore the anti-tumor effect of LIP-PFH nanoparticles triggered by low-intensity focused ultrasound (LIFU) both in vitro and in vivo. Flow cytometry and immunohistochemistry of CD4 + T, CD8 + T, CD8 + PD-1 + T in blood, spleen and tumor tissue were performed to represent the change of immune response. Detection of immunogenic cell death (ICD) markers was examined to study the potential mechanisms. Results: LIP-PFH nanoparticles triggered by LIFU could inhibit the proliferation and promote the apoptosis of 4T1 cells both in vitro and in vivo. CD4 + T and CD8 + T cell subsets were significantly increased in blood, spleen and tumor tissue, meanwhile CD8 + PD-1 + T cells were reduced, indicating enhancement of anti-tumor immune response of breast cancer cells in the nanoparticle-mediated SDT group. Detection of ICD markers (ATP, high-mobility group box B1, and calreticulin) and flow cytometric analysis of dendritic cell (DC) maturity further showed that the nanoparticle-mediated SDT can promote DC maturation to increase the proportion of cytotoxic T cells by inducing ICD of breast cancer cells. Conclusion: The therapy of nanoparticles-mediated SDT can effectively enhance anti-tumor immune response of breast cancer. Keywords: breast cancer, immune response, phase-transformation nanoparticles, immunogenic cell death, DC maturation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“SDT can induce ICD and trigger anti-tumor immunity [88–91]”
From Nanosensitizer-assisted sonodynamic therapy for breast cancer (2025) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Li, M., Luo, H., Zhang, W., He, K., Chen, Y., Liu, J., Chen, J., Wang, D., Hao, L., Ran, H., et al. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s166200 · Cited by 16
Self-citationRetractedCancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer
Schmid, P., Adams, S., Rugo, H. S., Schneeweiss, A., Barrios, C. H., Iwata, H., Diéras, V., Hegg, R., Im, S.-A., Shaw Wright, G., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1809615 · Cited by 4,350
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
Nanoparticle‐Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
Duan, X., Chan, C., & Lin, W. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201804882 · Cited by 1,033
Breast Cancer Immunotherapy: Facts and Hopes
Emens, L. A. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3001 · Cited by 863
Kitamura, T., Qian, B.-Z., Soong, D., Cassetta, L., Noy, R., Sugano, G., Kato, Y., Li, J., & Pollard, J. W. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141836 · Cited by 651
Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond
Ai, L., Xu, A., & Xu, J. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-15-3266-5_3 · Cited by 526
Lu, J., Liu, X., Liao, Y.-P., Salazar, F., Sun, B., Jiang, W., Chang, C. H., Jiang, J., Wang, X., Wu, A. M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01651-9 · Cited by 440
Self-citationLiang, S., Deng, X., Chang, Y., Sun, C., Shao, S., Xie, Z., Xiao, X., Ma, P., Zhang, H., Cheng, Z., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b01595 · Cited by 436
Research works printed but not linked: 1
- Kuroki, 2007, Anticancer Res, 27, 3673
Cited by
Application of nanosonosensitizer materials in cancer sono-dynamic therapy
Hu, C., Hou, B., & Xie, S. (2022) · RSC Advances · doi:10.1039/d2ra03786f · Cited by 85
A Comprehensive Review of Inorganic Sonosensitizers for Sonodynamic Therapy
Chen, P., Zhang, P., Shah, N. H., Cui, Y., & Wang, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512001 · Cited by 91
“Firstly, SDT treatment can enhance the activation of T cells and the antigen presentation process to better recognize and eliminate cancer cells [38].”
BackgroundSonodynamic therapy: Ultrasound parameters and in vitro experimental configurations
Martins, Y. A., Pavan, T. Z., & Lopez, R. F. V. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121243 · Cited by 87
Ultrasound Molecular Imaging and Its Applications in Cancer Diagnosis and Therapy
Zhang, G., Ye, H.-R., Sun, Y., & Guo, Z. (2022) · ACS Sensors · doi:10.1021/acssensors.2c01468 · Cited by 66
Liu, Q., Zhang, W., Jiao, R., Lv, Z., Lin, X., Xiao, Y., & Zhang, K. (2022) · Advanced Science · doi:10.1002/advs.202203921 · Cited by 63
Wang, T., Peng, W., Du, M., & Chen, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1167105 · Cited by 58
Engineering Versatile Nanomedicines for Ultrasonic Tumor Immunotherapy
Liang, J., Qiao, X., Qiu, L., Xu, H., Xiang, H., Ding, H., & Chen, Y. (2023) · Advanced Science · doi:10.1002/advs.202305392 · Cited by 57
Zheng, J., Sun, Y., Long, T., Yuan, D., Yue, S., Zhang, N., & Yang, Z. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2058653 · Cited by 53
“These results indicated that SDT is a potential method to turn “cold” tumors into “hot” tumors and may improve the therapeutic effects of ICIs.”
BackgroundInfluentialTemozolomide-based sonodynamic therapy induces immunogenic cell death in glioma
Zhou, Y., Jiao, J., Yang, R., Wen, B., Wu, Q., Xu, L., Tong, X., & Yan, H. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109772 · Cited by 49
Nanosensitizer-assisted sonodynamic therapy for breast cancer
Yu, J., Hu, J.-R., Tian, Y., Lei, Y.-M., Hu, H.-M., Lei, B.-S., Zhang, G., Sun, Y., & Ye, H.-R. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03311-3 · Cited by 43
“SDT can induce ICD and trigger anti-tumor immunity [88–91]; however, the immune response induced by SDT was insufficient to trigger a strong immune response.”
Sonodynamic and Acoustically Responsive Nanodrug Delivery System: Cancer Application
Jeong, Y., Park, J., & Khang, D. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s496028 · Cited by 43
Design of smart nanomedicines for effective cancer treatment
Aghda, N. H., Dabbaghianamiri, M., Tunnell, J. W., & Betancourt, T. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121791 · Cited by 40
Du, M., Wang, T., Peng, W., Feng, R., Goh, M., & Chen, Z. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02437-0 · Cited by 38
“By encapsulating or conju-gating sonosensitizers onto nanoparticles [12], their stability can be improved, leading to prolonged circulation and increased accumulation within tumors [13, 14].”
BackgroundApplication of Nanomaterial-Based Sonodynamic Therapy in Tumor Therapy
Yang, N., Li, J., Yu, S., Xia, G., Li, D., Yuan, L., Wang, Q., Ding, L., Fan, Z., & Li, J. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16050603 · Cited by 44
“Moreover, several studies have demonstrated that the cell death induced by US cavitation is more immunogenic [30,33], which enhances the strategy of SDT-induced ICD, turning “cold” tumors into “hot” tumors and strengthening the antitumor immune response [34,35].”
BackgroundImmunogenic cell death-based cancer vaccines: promising prospect in cancer therapy
Wang, J., Ma, J., Xie, F., Miao, F., lv, L., Huang, Y., Zhang, X., Yu, J., Tai, Z., Zhu, Q., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1389173 · Cited by 41
Chen, Y., Luo, X., Liu, Y., Zou, Y., Yang, S., Liu, C., & Zhao, Y. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s376172 · Cited by 33
Abolhassani, H., Eskandari, A., Poor, A. S., Zarrabi, A., Khodadadi, B., Karimifard, S., Sahrayi, H., Bourbour, M., & Yaraki, M. T. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.215754 · Cited by 36
Advances in Ultrasound-Targeted Microbubble Destruction (UTMD) for Breast Cancer Therapy
Wu, Y., Liu, Y.-X., Wu, H., Tong, M., Du, L.-Y., Ren, S., & Che, Y. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s504363 · Cited by 30
Progress in nanomedicine for sonodynamic immunotherapy of tumors
Feng, Z., Wang, Z., Xiang, X., Wang, L., Du, F., Xiao, X., Zhu, B., Rong, X., & Qiu, L. (2024) · EngMedicine · doi:10.1016/j.engmed.2024.100027 · Cited by 25
Self-citationThe roles of ultrasound-responsive nanomaterials in enhancing cancer immunotherapy
Wang, X., Wang, C., Liu, W., Thakur, A., Zhang, K., Xu, Z., & Li, J. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107975 · Cited by 24
Self-citationWang, T., Du, M., Yuan, Z., Guo, J., & Chen, Z. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.10.013 · Cited by 24
Zhu, L., Wang, X., Ding, M., Yu, N., Zhang, Y., Wu, H., Zhang, Q., Liu, J., & Li, J. (2023) · Biomaterials Science · doi:10.1039/d3bm00585b · Cited by 23
Self-citationUltrasound-induced immune responses in tumors: A systematic review and meta-analysis
Rix, A., Heinrichs, H., Porte, C., Leenaars, C., Bleich, A., & Kiessling, F. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.05.030 · Cited by 21
Recent advances in sonodynamic immunotherapy
Du, J., Wang, Y., Yue, Z.-H., Zhang, H., Wang, H., Sui, G., & Sun, Z. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04190-z · Cited by 22
“To study the relationship between SDT mediated by phase transformation nanoparticles and the immune response, In Yuan’s study (Si et al. 2021; Su et al. 2015), they prepared phase-transformation perfluorocarbon nanoparticles (LIPPFH nanoparticles).”
MethodWang, Y., Yang, R., Xie, Y., Zhou, X., Yang, J.-F., Shi, Y., & Liu, S. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01482-1 · Cited by 23
“P F H [ 136 ] , HN -”
Ultrasound nanomedicine and materdicine
Wang, Z., Wang, X., Chang, M., Guo, J., & Chen, Y. (2023) · Journal of Materials Chemistry B · doi:10.1039/d2tb02640f · Cited by 22
Self-citationMa, Y., Liu, Y., Qin, Z., Shen, Y., & Sun, M. (2022) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2022.104056 · Cited by 17
Jiang, Y., Cao, Y., Yao, Y., Zhang, D., & Wang, Y. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140144 · Cited by 19
Zhang, R., Wang, Q., Pan, J., Du, J., Yang, H. N., Wang, B., Li, Y., Miao, Y., Hou, X., Wu, J., et al. (2025) · Advanced Science · doi:10.1002/advs.202413519 · Cited by 15
Enhancing immunogenicity and release of in situ-generated tumor vesicles for autologous vaccines
Chen, J., Zhao, C., Zhang, J., Cheng, J.-W., Hu, J., Yu, P. L., Yang, M., Xia, Y., Yin, Y., Zhang, Z., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113614 · Cited by 13
Yang, M., Zhang, W., Su, L., Chen, Q., Liu, W., Dai, M., & Ran, H. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.161735 · Cited by 11
Zeng, Z., Tian, T., Liu, J., Bai, L., Zhang, J., Nie, C., Liu, B., Chen, C., & Lü, W. (2026) · RSC Advances · doi:10.1039/d5ra03591k · Cited by 11
Wei, M., Wang, X., Mo, Y., Kong, C., Zhang, M., Qiu, G., Tang, Z., Chen, J., & Wu, F. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s427144 · Cited by 10
“13 However, some studies suggest that ICD alone may not consistently yield optimal therapeutic outcomes as anticipated.”
BackgroundSelf-citationZhou, Y., Huang, X., Wu, D., Xie, X., Li, H., Wang, Q., Liao, Y., & Li, H. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.159704 · Cited by 10
Therapeutic Ultrasound for Multimodal Cancer Treatment: A Spotlight on Breast Cancer
Demir, Z. E. F., & Sheybani, N. (2025) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-103023-111151 · Cited by 13
“By immunohistochemistry, elevations in CD4 + and CD8 + T cells and a decline in programmed cell death protein 1 (PD-1) expression on tumor-infiltrating T cells were observed (84).”
Chen, Y.-C., Mao, K., Han, D., Ma, R., Sun, T., Zhang, H., & Han, B. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1511423 · Cited by 11
Tumor Microenvironment‐Related Sonodynamic Therapy Mediates Tumor Therapy
Wang, X., Wang, C., Tian, H., Wu, B., & Cheng, W. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300265 · Cited by 9
Self-citationShah, H. A., Slika, H., Ruchika, F., Golub, D., Schulder, M., Brem, H., Manbachi, A., Rincón-Torroella, J., Bettegowda, C., Anastasiadis, P., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118433 · Cited by 8
Du, Y., Yang, J., Xu, A., Chen, S., & Fu, D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1681773 · Cited by 10
A Minireview on Nanosized Hypericin-Based Inducer of Immune Cell Death Under ROS-Based Therapies
Xu, C., Cai, X., & Du, L. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s566489 · Cited by 5
“91,92 Yuan et al used a hematoporphyrin monomethyl ether (HMME)-based liposomal nanosystem as a sonosensitizer for colon cancer treatment.”
Du, F., Zhao, H., Guo, R., Huang, J., Feng, Z., Wang, Z., & Li, Q. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.171503 · Cited by 4
Self-citationRix, A., Girbig, R. M., Porte, C., Lederle, W., Leenaars, C. H. C., & Kiessling, F. M. (2021) · Molecular Imaging and Biology · doi:10.1007/s11307-021-01686-x · Cited by 3
Luo, C., Wu, D., Peng, S., Xu, S., Zhang, D., Huang, X., Qin, W., Li, H., & Li, H. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04079-w · Cited by 2
Yao, Y., Zhang, Q., Wei, S., Li, H., Zhou, T., Zhang, Q., Zhang, J., Zhang, J., & Wang, H. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-2243 · Cited by 3
“Encode the CD4 membrane glycoprotein of T lymphocytes. initiate or augment the early phase of T-cell activation, and may function as an important mediator of indirect neuronal damage in infectious and immune-mediated diseases of the central nervous system (55-57)”
Ayyami, Y., Dastgir, M., Yektamanesh, M., Zamani, H., Jazi, S. S., Arjmand, B., Siegel, A. P., Mehrizi, O. A., Manwar, R., Hamishehkar, H., et al. (2026) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2026.107750 · Cited by 1
Tatiparthi, R., Panda, A., Chaitanya, M., Gashe, F., Hasan, G., & Yarlagadda, R. (2026) · Molecular Imaging and Biology · doi:10.1007/s11307-026-02090-z · Cited by 3
“When combined with chemotherapy or immunotherapy, SDT increases oxidative stress and enhances activation of multiple cell death pathways, providing a potent strategy for eradicating MDR tumour populations [53].”
Zhang, C., Shu, B., Wang, X., Shen, X., Du, Y., Yang, J., & Miao, Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1845672 · Cited by 1
“…by 72%), promotes TAA release and DCs in fi ltration; in the B16F10 model, the proportion of CD11c + MHC-II + DCs in tumor draining lymph nodes (TDLN) increased to 52%, and the distal tumor inhibition rate reached 68%, demonstrating its ef fi cacy in remodeling TME and inducing distal effects (103).”
Du, M., Wang, T., Peng, W., Feng, R., Goh, M., & Chen, Z. (2024) · Figshare · doi:10.6084/m9.figshare.25596335
Mirzaei, G., Mazloumi, Z., & Khoshfetrat, A. B. (2025) · National and International Iranian Conference on Biomedical Engineering (ICBME) · doi:10.1109/icbme68496.2025.11392530
Chen, W., Chen, C., Hu, Z., Li, F., Peng, Y., & Zhang, M. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-026-05526-w
“M2-polarized M2-polarized TAMs are immunosuppressive and able to promote the tumor development [32 ].”
Beyond Ablation: A Review of Immune Responses Across Focused Ultrasound Modalities
Elliott, C. M., Paul, T., Hall, M., Killar, S., Vlaisavljevich, E., & Allen, I. C. (2026) · Cancers · doi:10.3390/cancers18152460
“A recurring feature across these studies is the induction of acute cellular stress and subsequent release of DAMPs following LIFU-mediated mechanical disruption (Table 1) [114,115].”
InfluentialPan, T., Feng, Z., Shang, T., Jiang, J., & Fang, Z. (2026) · International Journal of Oncology · doi:10.3892/ijo.2026.5930
“Immunohistochemistry was performed to observe the markers of ICD, CRT and HMGB1, using an indirect peroxidase method (41).”
Metadata
- Authors
- Si, Y., Yue, J., Liu, Z., Li, M., Du, F., Wang, X., Dai, Z., Hu, N., Ju, J., Gao, S., Wang, X., & Yuan, P.
- Affiliations
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University Cancer Hospital (CN)
- Cancer Hospital of Huanxing Chaoyang District Beijing (CN)
- Corresponding author
- Yuan, Peng
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2021-03
- Volume
- Volume 16
- Pages
- 1913-1926
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- PMC
- PMC7943766
- OpenAlex
- W3134420868
- Cited by
- 52
- References
- 40
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 13 · 2023: 7 · 2022: 8 · 2021: 2
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Nanomedicine (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81672634)
- Chinese Academy of Medical Sciences (12019XK320071)
- Chinese Society of Clinical Oncology (Y-2019AZMS-0377)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Engineering › Biomedical Engineering › Ultrasound and Hyperthermia Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Photodynamic Therapy Research Studies
- Keywords
- sonodynamic therapy, low-intensity focused ultrasound, breast cancer, immunogenic cell death, antitumor immunity, dendritic cell maturation, CD8+ T cells, PD-1, apoptosis, 4T1 cells, calreticulin, HMGB1, cancer immunotherapy
- MeSH terms
- Immunogenic Cell Death, Animals, Dendritic Cells, Endocytosis, Female, Fluorocarbons, Immunity, Immunotherapy, Mice, Inbred BALB C, T-Lymphocytes, T-Lymphocytes, Cytotoxic, Ultrasonic Therapy, Mammary Neoplasms, Animal, Apoptosis, Cell Line, Tumor, Mice, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.